Crossmark

Why Use Aprepitant Only as a Cough Suppressant in Lung Cancer When at Higher Doses it Could Also Exert an Antitumor Action?

Crossref DOI link: https://doi.org/10.1016/j.arbres.2022.05.004

Published Print: 2022-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Muñoz, Miguel

Muñoz, Miguel E.

Morell, Ferran

Coveñas, Rafael
License Information

Text and Data Mining valid from 2022-10-01
More Information

This article is maintained by: Elsevier

Article Title: Why Use Aprepitant Only as a Cough Suppressant in Lung Cancer When at Higher Doses it Could Also Exert an Antitumor Action?

Journal Title: Archivos de Bronconeumología

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.arbres.2022.05.004

Content Type: simple-article

Copyright: © 2022 SEPAR. Published by Elsevier España, S.L.U. All rights reserved.